[1] Robbie G. Majzner, et al. Clinical lessons learned from the first leg of the CAR T cell journey. Nature Medicine. (2019) [2] Roddie, C., et al. Manufacturing chimeric antigen receptor T cells: issues and challenges. Cytotherapy. (2019)[3] Rebecca C. Larson, et al. Recent advances and discoveries in the mechanisms and functions of CAR T cells. (2021)[4] Robert C. Sterner, et al. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer Journal. (2021) [5] Andrew J. Hou, et al. Navigating CAR-T cells through the solid-tumour microenvironment. Nature Reviews Drug Discovery. (2021) [6] S. Depil, et al. ‘Off-the-shelf’ allogeneic CAR T cells: development and challenges. Nature Reviews Drug Discovery . (2020)